Skip to content

Hair growth effect by using a test article selected based on genetic testing

Hair growth effect by using a test article selected based on genetic testing: a randomized, double blind, placebo-controlled study - Hair growth effect by using a test article selected based on genetic testing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047310
Enrollment
34
Registered
2022-04-01
Start date
2022-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Use test products selected based on genetic testing for 24 weeks No using test articles selected based on genetic testing. For 24 weeks , use test articles that differ from the test results Use placeb

Sponsors

Japan Clinical Trial Association
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who are aware of thinning hair and can see through the scalp

Exclusion criteria

Exclusion criteria: 1. Factors that may affect the results of the test at the evaluation region (disease such as atopic dermatitis and urticaria, inflammation, eczema, trauma, acne, pimples, warts, stains, etc., or traces thereof) 2. Subjects who have received aesthetic medicine (hair transplantation, etc.) or AGA treatment at the evaluation region, or who plan to receive it during the test period 3. Subjects who regularly use medicines, quasi-drugs, cosmetics, health foods, and supplements that claim to have a hair-growth effect. 4. Subjects who have been exposed to UV rays beyond their daily lives, such as long hours of outdoor work, exercise, swimming, leisure, etc. within the past 4 weeks, or who plan to do so during the test period. 5. Subjects who work night shifts and shift work day and night 6. At the time of obtaining consent, it is judged that the subjects is receiving treatment (hormone replacement therapy, drug therapy, exercise therapy, diet therapy, etc.) at a medical institution for the treatment or prevention of the disease, or that treatment is necessary. 7. Subjects who have a history of serious or mental illness of glucose metabolism, lipid metabolism, liver function, renal function, heart, circulatory organs, respiratory organs, endocrine system, immune system, nervous system. 8. Excessive smokers * and alcohol addicts ** and subjects with extremely irregular diets 9. Subjects who are at risk of developing allergies to cosmetics and foods (including subjects who have developed skin abnormalities such as rashes on cosmetics within the past year) 10. Subjects who have participated in other human tests (all tests for humans using cosmetics, foods, pharmaceuticals, quasi-drugs, medical devices, etc.) within the past 4 weeks, or are planning to conduct this test. Subjects who plan to participate in other human studies during the period

Design outcomes

Primary

MeasureTime frame
hair thickness measurement, evaluation of scalp condition

Countries

Japan

Contacts

Public ContactTakeshi Kaneko

Japan Clinical Trial Association N.A.

info@yakujihou.org0364574666

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026